Northwestern School of Medicine - The Miller Lab
The Nash Group supports The Miller Lab
and we encourage others to do the same. Named for Dr. Stephen Miller, Professor and Director of the Interdepartmental Immunobiology Center at the Northwestern School of Medicine, we are grateful for their commitment to research on multiple sclerosis (MS).
In MS, the immune system attacks and destroys myelin, the insulating layer that forms around nerves in the spinal cord, brain and optic nerve. When the insulation is destroyed, electrical signals can’t be effectively conducted, resulting in symptoms that range from mild limb numbness to paralysis or blindness.
In 2013, Dr. Miller, the co-senior author of a paper on the study, which was published June 5 in the journal Science Translational Medicine. The study is a collaboration between Northwestern’s Feinberg School, University Hospital Zurich in Switzerland and University Medical Center Hamburg-Eppendorf in Germany.
The human trial is the translation of more than 30 years of pre-clinical research in Miller's lab.
“The therapy stops autoimmune responses that are already activated and prevents the activation of new autoimmune cells,” said Stephen Miller, the Judy Gugenheim Research Professor of Microbiology-Immunology at Northwestern University Feinberg School of Medicine. “Our approach leaves the function of the normal immune system intact. That’s the holy grail.”
The Nash Group applauds the Miller Lab and we encourage others to support their research.
See more here